- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Roche Holding AG Participation (ROPC)
The Roche Holding Participation share price today is 334.20, view SIX ROPC stock exchange data. Track the latest Roche Holding Participation share price with real-time updates on ROPC stock performance including market cap, day range, 52-week range and dividend yield. Access ROPC charts, earnings dates and analyst estimates to support your investment decisions.
Switzerland
Currency in CHF
334.20
+2.60(+0.78%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
330.90
336.30
52 wk Range
243.90
374.90
Earnings results expected in 5 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
330.90336.30
52 wk Range
243.90374.90
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.96%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.96%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
ROPC Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Price Target
359.22
Upside
+7.49%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with low price volatility
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy
Analyst Ratings
8 Buy
7 Hold
2 Sell
Ratings:
17 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 359.22
(+7.49% Upside)
Roche Holding AG Participation Earnings Call Summary for H2/2025
- Roche's Q4 2025 EPS of 8.37 missed forecasts by 19.13%, while revenue exceeded expectations at 15.65 billion CHF, a 0.64% positive surprise.
- Pharmaceutical division drove 7% group sales growth with a 9% increase to 47.7 billion CHF; core operating profit improved by 13% despite the quarterly EPS miss.
- Management forecasts mid-single-digit sales growth and high single-digit core EPS growth for 2026, with several new molecular entities advancing to Phase 3.
- Stock showed resilience with a 3.67% pre-market increase despite the earnings miss, reflecting investor confidence in revenue performance and pipeline potential.
- Analysts expressed particular interest in giredestrant's market potential and fenebrutinib's prospects in multiple sclerosis treatment during the Q&A session.
Last Updated: 03-02-2026, 04:00 pm
Read Full TranscriptEarnings
Latest Release
23-04-2026
EPS / Forecast
10.56 / --
Revenue / Forecast
14.72B / 15.19B
Compare ROPC to Peers and Sector
Metrics to compare | ROPC | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipROPCPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | 26.7x | −0.4x | |
PEG Ratio | 0.00 | 0.23 | 0.00 | |
Price/Book | 0.0x | 6.6x | 2.6x | |
Price / LTM Sales | 0.0x | 5.0x | 3.0x | |
Upside (Analyst Target) | 0.0% | 1.2% | 50.8% | |
Fair Value Upside | Unlock | 8.3% | 9.4% | Unlock |
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions. Roche Holding AG has a collaboration agreement with Excalipoint Therapeutics to evaluate EXP011 in DLL3-expressing solid tumors. The company was founded in 1896 and is based in Basel, Switzerland.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the Roche Holding Participation (ROPC) Share Price Today?
The Roche Holding Participation share price today is 334.20.
What is the current Roche Holding Participation (ROPC) share price and day range?
As of 18-07-2026, the Roche Holding Participation share price is 334.20, with a previous close of 331.60. The share price has ranged from 330.90 to 336.30 today, while the 52-week range spans from 243.90 to 374.90.
What Is the Roche Holding Participation Market Cap?
As of today, Roche Holding Participation market cap is 266.47B.
Does Roche Holding Participation Pay Dividends? What's The Current Dividend Yield?
The Roche Holding Participation dividend yield is 2.96%.
What Is the Roche Holding Participation (ROPC) Share Price Target?
The average 12-month share price target for Roche Holding Participation is 359.22, with a high estimate of 428 and a low estimate of 230. 8 analysts recommend buying, while 2 suggest selling, with an overall rating of Buy and +7.49% Upside potential.
What Is Roche Holding Participation's Earnings Per Share (TTM)?
The Roche Holding Participation EPS (TTM) is 16.04.
When Is the Next Roche Holding Participation Earnings Date?
Roche Holding Participation will release its next earnings report on 23-07-2026.
From a Technical Analysis Perspective, Is ROPC a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
What Stock Exchange Does Roche Holding Participation Trade On?
Roche Holding Participation is listed and trades on the Switzerland Stock Exchange.
What Is the Stock Symbol for Roche Holding Participation?
The stock symbol for Roche Holding Participation is "ROPC."
How Many Times Has Roche Holding Participation Stock Split?
Roche Holding Participation has split 1 times.
How Many Employees Does Roche Holding Participation Have?
Roche Holding Participation has 103249 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.